More articles from Accepted Article

You have accessAccepted Article
Effectiveness of a second biologic after failure of a non-tumor necrosis factor inhibitor as first biologic in rheumatoid arthritis
Katerina Chatzidionysiou, Merete Lund Hetland, Thomas Frisell, Daniela Di Giuseppe, Karin Hellgren, Bente Glintborg, Dan Nordström, Ritva Peltomaa, Kalle Aaltonen, Nina Trokovic, Eirik K. Kristianslund, Tore K. Kvien, Sella A. Provan, Bjorn Gudbjornsson, Gerdur Grondal, Lene Dreyer, Lars Erik Kristensen, Tanja Schjødt Jørgensen, Lennart T.H. Jacobsson and Johan Askling

The Journal of Rheumatology March 1 2021, jrheum.201467; DOI: https://doi.org/10.3899/jrheum.201467
You have accessAccepted Article
Trajectory of Healthcare Resources Utilization in Giant Cell Arteritis – A Population-Based Study
Aladdin J. Mohammad, Aleksandra Turkiewicz, Pavlos Stamatis, Carl Turesson, Martin Englund and Ali Kiadaliri

The Journal of Rheumatology March 1 2021, jrheum.201131; DOI: https://doi.org/10.3899/jrheum.201131
You have accessAccepted Article
Relationship between the dynamics of telomere loss in peripheral blood leukocytes from osteoarthritis patients and mitochondrial DNA haplogroup
Rebeca Guillén Fajardo, Fátima Otero Fariña, Alejandro Mosquera Rey, Ignacio Rego-Pérez, Francisco Javier Blanco García and José Luis Fernández García

The Journal of Rheumatology March 1 2021, jrheum.201316; DOI: https://doi.org/10.3899/jrheum.201316
Open AccessAccepted Article
Re-thinking Physical Activity Promotion during COVID-19 Pandemic: Focus on a 24-hour Day
Linda C. Li, Lynne M. Feehan and Alison M. Hoens

The Journal of Rheumatology February 15 2021, jrheum.201595; DOI: https://doi.org/10.3899/jrheum.201595
You have accessAccepted Article
Real-world risk of relapse of giant cell arteritis treated with tocilizumab: A retrospective analysis of 43 patients
Jérémy Clément, Pierre Duffau, Joel Constans, Thierry Schaeverbeke, Jean-Francois Viallard, Damien Barcar, Jean-Philippe Vernhes, Laurent Sailler and Fabrice Bonnet

The Journal of Rheumatology February 15 2021, jrheum.200952; DOI: https://doi.org/10.3899/jrheum.200952
You have accessAccepted Article
Evaluation and validation of a patient completed psoriatic arthritis flare questionnaire
Philip S. Helliwell, William Tillett, Robin Waxman, Laura C. Coates, Mel Brooke, Oliver FitzGerald, Jonathan C. Packham and Neil McHugh on behalf of the PROMPT study group

The Journal of Rheumatology February 15 2021, jrheum.201317; DOI: https://doi.org/10.3899/jrheum.201317
You have accessAccepted Article
A phase III randomized study of apremilast, an oral phosphodiesterase 4 inhibitor, for active ankylosing spondylitis
Peter C. Taylor, Désirée van der Heijde, Robert Landewé, Shannon McCue, Sue Cheng and Annelies Boonen

The Journal of Rheumatology February 15 2021, jrheum.201088; DOI: https://doi.org/10.3899/jrheum.201088
Open AccessAccepted Article
Multimorbidity Burden in Rheumatoid Arthritis: A Population-Based Cohort Study
Tina M. Gunderson, Elena Myasoedova, John M. Davis III and Cynthia S. Crowson

The Journal of Rheumatology February 15 2021, jrheum.200971; DOI: https://doi.org/10.3899/jrheum.200971
Open AccessAccepted Article
Improved Incidence of Cardiovascular Disease in Patients with Incident Rheumatoid Arthritis in the 2000s: a Population-Based Cohort Study
Elena Myasoedova, John M. Davis III, Veronique L. Roger, Sara J. Achenbach and Cynthia S. Crowson

The Journal of Rheumatology February 15 2021, jrheum.200842; DOI: https://doi.org/10.3899/jrheum.200842
You have accessAccepted Article
Efficacy of moderately dosed etoposide in macrophage activation syndrome - hemophagocytic lymphohistiocytosis (MAS-HLH)
AnnaCarin Horne, Tatiana von Bahr Greenwood, Samuel C.C. Chiang, Marie Meeths, Caroline Björklund, Maria Ekelund, Peter Erensjö, Stefan Berg, Stefan Hagelberg, Yenan T. Bryceson, Ulf Andersson and Jan-Inge Henter

The Journal of Rheumatology February 15 2021, jrheum.200941; DOI: https://doi.org/10.3899/jrheum.200941

Main menu

User menu

Search

More articles from Accepted Article

Pages

Content

Resources

Subscribers

More